Advertisement

Topics

Zealand starts enrolment in Phase III trial of dasiglucagon for hypoglycemia

19:00 EDT 3 Jul 2017 | Net Resources International

Denmark-based biotechnology firm Zealand Pharma has started patient enrolment in Phase III clinical trial of dasiglucagon to treat severe hypoglycaemia in diabetic patients.

Original Article: Zealand starts enrolment in Phase III trial of dasiglucagon for hypoglycemia

NEXT ARTICLE

More From BioPortfolio on "Zealand starts enrolment in Phase III trial of dasiglucagon for hypoglycemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...